Aging populations and increased incidences of chronic diseases across the Asia-Pacific region are spurring rapid growth in demand for in-vitro diagnostic (IVD) testing. That presents major marketing opportunities for the diagnostics industry in China, India, Southeast Asia, Japan, South Korea, and Indonesia. ... Read More
The COVID-19 pandemic is hampering the initiation and progress of clinical trials in Asia and around the world. Few patients are entering studies, and trials of new treatments are on hold. In Korea, the number of new patients enrolling in clinical... Read More
Moving to further streamline and modernize its process for reviewing therapeutic products, the Therapeutic Products Branch of Singapore’s Health Sciences Authority (HSA) is instituting a new online documentation process. The new form will allow applicants to file registrations for multiple products through... Read More
This article was originally published on MedTech Intelligence. With the COVID-19 pandemic shuttering physician offices and walk-in clinics, patients and doctors across Asian markets have turned increasingly to telehealth solutions. The surge is creating a short-term boom—and the likelihood of a long-term... Read More
https://attendee.gotowebinar.com/recording/5890292005019691021 Read More
Medical devices marketed and distributed in Singapore have long been subject to strict requirements that mandate any safety hazards associated with their use be reported to government authorities. Now a new online system makes reporting of what is known in Singapore as... Read More
This article was originally published on MedTech Intelligence. Led by Chinese Internet commerce giants Tencent and Alibaba, internet providers have been offering a vast array of cloud computing services free to researchers and clinicians, while hiking their investment in advanced technologies, since... Read More
New regulatory guidelines released by Singapore’s Health Sciences Authority outline specific requirements required to register next-generation sequencing-based in vitro diagnostic tests, known as NGS IVDs, in the country. The new registration regulations are designed to address rapid advances in genomic technology that... Read More
With the COVID-19 pandemic impacting clinical trials worldwide, Singapore is among the countries that have issued guidance for sponsors, investigators, and review boards on handling trials that were already in progress. Under the guidance issued by Singapore’s Health Sciences Authority (HSA), sponsors... Read More
Pharmaceutical companies seeking to deepen penetration of Singapore’s market are coming up against barriers to ensuring their intellectual property is protected and to keeping down costs of conducting clinical trials. The pharma industry is rising in importance in the country’s manufacturing sector.... Read More